![Jeff Roix](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jeff Roix
Nessuna posizione attualmente
Profilo
Jeff Roix worked as the Chief Operating Officer at PhoreMost Ltd..
Mr. Roix attended Harvard Extension School for his undergraduate degree.
Precedenti posizioni note di Jeff Roix
Società | Posizione | Fine |
---|---|---|
PhoreMost Ltd.
![]() PhoreMost Ltd. Pharmaceuticals: MajorHealth Technology PhoreMost Ltd. operates as a drug discovery company. It engages in identifying new druggable targets for cancer and other unmet diseases. PhoreMost uses SiteSeeker technology, a live-cell phenotypic assay system that can identify unexpected, or cryptic druggable sites in specific disease driving targets and pathways that can?t be readily seen using conventional non-cell based analytical methods. The company was founded by Christopher John Torrance and Ashok Venkitaraman on April 1, 2014 and is headquartered in Cambridge, the United Kingdom. | Direttore operativo | - |
Formazione di Jeff Roix
Harvard Extension School | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Società collegate
Aziende private | 1 |
---|---|
PhoreMost Ltd.
![]() PhoreMost Ltd. Pharmaceuticals: MajorHealth Technology PhoreMost Ltd. operates as a drug discovery company. It engages in identifying new druggable targets for cancer and other unmet diseases. PhoreMost uses SiteSeeker technology, a live-cell phenotypic assay system that can identify unexpected, or cryptic druggable sites in specific disease driving targets and pathways that can?t be readily seen using conventional non-cell based analytical methods. The company was founded by Christopher John Torrance and Ashok Venkitaraman on April 1, 2014 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Jeff Roix